1. Home
  2. HOOK
  3. HOOK News

Latest HOOKIPA Pharma Inc. (HOOK) News on June 28, 2025

Gilead (GILD) to Acquire HOOK for $10 million
HOOK

Insider Monkey

a month ago

Gilead (GILD) to Acquire HOOK for $10 million

HOOK

MT Newswires

a month ago

HOOKIPA to Sell HBV, HIV Program Assets to Gilead; Shares Rise

HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)
HOOK

GlobeNewswire

4 months ago

HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)

Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial
HOOK

TipRanks

5 months ago

Hookipa Pharma announces enrollment completion of Phase 1b HB-500 trial

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
HOOK

GlobeNewswire

5 months ago

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV

HOOK

MT Newswires

6 months ago

HC Wainwright Downgrades HOOKIPA Pharma to Neutral From Buy

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
HOOK

GlobeNewswire

6 months ago

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA

HOOKIPA Pharma Inc - FORM 8 (OPD)
HOOK

GlobeNewswire

6 months ago

HOOKIPA Pharma Inc - FORM 8 (OPD)

HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements
HOOK

GlobeNewswire

6 months ago

HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA
HOOK

GlobeNewswire

6 months ago

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA

HOOKIPA Pharma Inc. (“HOOKIPA”) Rule 2.9 Announcement – Amendment
HOOK

GlobeNewswire

6 months ago

HOOKIPA Pharma Inc. (“HOOKIPA”) Rule 2.9 Announcement – Amendment

HOOK

MT Newswires

6 months ago

Hookipa Pharma, Poolberg Pharma in Discussions for All-Stock Merger

Poolbeg Pharma plc (“Poolbeg” or the “Company”) Combination of Poolbeg and HOOKIPA Pharma Inc.
HOOK

GlobeNewswire

6 months ago

Poolbeg Pharma plc (“Poolbeg” or the “Company”) Combination of Poolbeg and HOOKIPA Pharma Inc.

Hookipa Pharma price target lowered to $7 from $24 at JMP Securities
HOOK

TipRanks

7 months ago

Hookipa Pharma price target lowered to $7 from $24 at JMP Securities

Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program
HOOK

TipRanks

7 months ago

Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program

HOOK

MT Newswires

7 months ago

Sector Update: Health Care Stocks Advance Late Afternoon

HOOK

MT Newswires

7 months ago

Sector Update: Health Care Stocks Climb Thursday Afternoon

HOOK

MT Newswires

7 months ago

HOOKIPA Pharma to Cut Workforce by 80%, Shift Focus to KRAS Cancer Program

Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky
HOOK

Simply Wall St.

7 months ago

Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky

HOOKIPA Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
HOOK

Simply Wall St.

7 months ago

HOOKIPA Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates
HOOK

GlobeNewswire

7 months ago

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates

HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker
HOOK

GlobeNewswire

8 months ago

HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker

HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024
HOOK

GlobeNewswire

8 months ago

HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer
HOOK

GlobeNewswire

8 months ago

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset
HOOK

GlobeNewswire

9 months ago

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset

Wall Street Analysts Think HOOKIPA Pharma (HOOK) Could Surge 622.75%: Read This Before Placing a Bet
HOOK

Zacks

10 months ago

Wall Street Analysts Think HOOKIPA Pharma (HOOK) Could Surge 622.75%: Read This Before Placing a Bet

HOOK

MT Newswires

10 months ago

HOOKIPA Pharma Names Julie O'Neill Nonexecutive Chair

HOOKIPA Pharma Announces Board of Directors Changes
HOOK

GlobeNewswire

10 months ago

HOOKIPA Pharma Announces Board of Directors Changes

HOOK

GlobeNewswire

10 months ago

HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

HOOKIPA Pharma Second Quarter 2024 Earnings: Revenues Miss Expectations
HOOK

Simply Wall St.

a year ago

HOOKIPA Pharma Second Quarter 2024 Earnings: Revenues Miss Expectations

HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Wall Street Analysts Believe HOOKIPA Pharma (HOOK) Could Rally 634.38%: Here's is How to Trade
HOOK

Zacks

a year ago

Wall Street Analysts Believe HOOKIPA Pharma (HOOK) Could Rally 634.38%: Here's is How to Trade

Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know
HOOK

Zacks

a year ago

Will HOOKIPA Pharma Inc. (HOOK) Report Negative Q2 Earnings? What You Should Know

HOOK

MT Newswires

a year ago

HOOKIPA Pharma Appoints Malte Peters CEO, Terry Coelho CFO

HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200

HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock Split
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock Split

HOOKIPA Pharma doses first subject in Phase Ib HIV treatment trial
HOOK

Clinical Trials Arena

a year ago

HOOKIPA Pharma doses first subject in Phase Ib HIV treatment trial

HOOK

MT Newswires

a year ago

HOOKIPA Pharma Reports First Patient Dosed in HIV Treatment Study

HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
HOOK

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
HOOK

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
HOOK

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge
HOOK

Bloomberg

a year ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally
HOOK

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
HOOK

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
HOOK

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
HOOK

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

Media Advisory - Prime Minister's itinerary for Sunday, June 9, 2024
HOOK

CNW Group

a year ago

Media Advisory - Prime Minister's itinerary for Sunday, June 9, 2024

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge
HOOK

ACCESSWIRE

a year ago

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies
HOOK

Business Insider

a year ago

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting
HOOK

GlobeNewswire

a year ago

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger
HOOK

Motley Fool

a year ago

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger

Unifor members vote to strike at Manitoba Hydro
HOOK

CNW Group

a year ago

Unifor members vote to strike at Manitoba Hydro

Croatia beat Portugal in Euro 2024 warm-up friendly
HOOK

AFP

a year ago

Croatia beat Portugal in Euro 2024 warm-up friendly

Mark Cuban explains how he helped turn 300 of his employees into millionaires
HOOK

Business Insider

a year ago

Mark Cuban explains how he helped turn 300 of his employees into millionaires

HOOK

MT Newswires

a year ago

HC Wainwright Adjusts Price Target on HOOKIPA Pharma to $6 From $5, Maintains Buy Rating

HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting

HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting

HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting

HOOKIPA Pharma First Quarter 2024 Earnings: Beats Expectations
HOOK

Simply Wall St.

a year ago

HOOKIPA Pharma First Quarter 2024 Earnings: Beats Expectations

HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab

Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
HOOK

Benzinga

a year ago

Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?

HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers

HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration

Time To Worry? Analysts Just Downgraded Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Outlook
HOOK

Simply Wall St.

a year ago

Time To Worry? Analysts Just Downgraded Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Outlook

HOOKIPA Pharma Inc. (HOOK) Reports Q4 Loss, Tops Revenue Estimates
HOOK

Zacks

a year ago

HOOKIPA Pharma Inc. (HOOK) Reports Q4 Loss, Tops Revenue Estimates

HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference

Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains?
HOOK

Zacks

a year ago

Absci Corporation (ABSI) Surges 10.0%: Is This an Indication of Further Gains?

All You Need to Know About HOOKIPA Pharma Inc. (HOOK) Rating Upgrade to Strong Buy
HOOK

Zacks

a year ago

All You Need to Know About HOOKIPA Pharma Inc. (HOOK) Rating Upgrade to Strong Buy

Best Momentum Stocks to Buy for February 2nd
HOOK

Zacks

a year ago

Best Momentum Stocks to Buy for February 2nd

NUTEX HEALTH ANNOUNCES YORKVILLE PAYOFF AND STREAMLINED STRATEGIC PLAN
HOOK

PR Newswire

a year ago

NUTEX HEALTH ANNOUNCES YORKVILLE PAYOFF AND STREAMLINED STRATEGIC PLAN

Strength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?
HOOK

Zacks

a year ago

Strength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?

HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs

Colony Bankcorp, Inc. (NASDAQ:CBAN) Q4 2023 Earnings Call Transcript
HOOK

Insider Monkey

a year ago

Colony Bankcorp, Inc. (NASDAQ:CBAN) Q4 2023 Earnings Call Transcript

BankFinancial Corporation Declares Cash Dividend
HOOK

GlobeNewswire

a year ago

BankFinancial Corporation Declares Cash Dividend

Middlefield Banc Corp. Reports 2023 Full-Year Financial Results
HOOK

GlobeNewswire

a year ago

Middlefield Banc Corp. Reports 2023 Full-Year Financial Results

SB Financial Group, Inc. (SBFG) Surpasses Q4 Earnings and Revenue Estimates
HOOK

Zacks

a year ago

SB Financial Group, Inc. (SBFG) Surpasses Q4 Earnings and Revenue Estimates

HOOK

GlobeNewswire

a year ago

Northern Star Investment Corp. II Announces Determination to Continue Corporate Existence

HOOK

GlobeNewswire

a year ago

SB Financial Group Announces Fourth Quarter and Full Year 2023 Results

HOOK

Associated Press Finance

a year ago

Colony Bankcorp: Q4 Earnings Snapshot

HOOK

GuruFocus.com

a year ago

Colony Bankcorp Inc (CBAN) Reports Mixed Fourth Quarter Results and Declares Dividend

Colony Bankcorp Reports Fourth Quarter 2023 Results
HOOK

Business Wire

a year ago

Colony Bankcorp Reports Fourth Quarter 2023 Results

Duluth Holdings Inc. Announces Appointment of Heena Agrawal as Chief Financial Officer
HOOK

GlobeNewswire

a year ago

Duluth Holdings Inc. Announces Appointment of Heena Agrawal as Chief Financial Officer

HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization
HOOK

GlobeNewswire

a year ago

HOOKIPA Pharma Appoints Mark Winderlich as Chief Development Officer to Lead Clinical Research and Development Organization

Evolution Petroleum Announces Acquisition of Non-operated Oil and Gas Assets
HOOK

GlobeNewswire

a year ago

Evolution Petroleum Announces Acquisition of Non-operated Oil and Gas Assets

ZeroFox to Participate in 26th Annual Needham Growth Conference
HOOK

GlobeNewswire

a year ago

ZeroFox to Participate in 26th Annual Needham Growth Conference

Meridian Bet Provides Update on Corporate Progress and Pending Acquisition
HOOK

GlobeNewswire

a year ago

Meridian Bet Provides Update on Corporate Progress and Pending Acquisition

Alico, Inc. to Attend the 2024 ICR Conference in Orlando, Florida
HOOK

GlobeNewswire

a year ago

Alico, Inc. to Attend the 2024 ICR Conference in Orlando, Florida

HOOK

GlobeNewswire

a year ago

SB Financial Group, Inc. Announces Schedule for Fourth Quarter and Full Year 2023 Results

Are Investors Undervaluing First United (FUNC) Right Now?
HOOK

Zacks

a year ago

Are Investors Undervaluing First United (FUNC) Right Now?

SB Financial Group (NASDAQ:SBFG) investors are sitting on a loss of 2.4% if they invested three years ago
HOOK

Simply Wall St.

a year ago

SB Financial Group (NASDAQ:SBFG) investors are sitting on a loss of 2.4% if they invested three years ago

Terran Orbital Reports an Excess of $70 Million Year-End Cash Balance
HOOK

Business Wire

a year ago

Terran Orbital Reports an Excess of $70 Million Year-End Cash Balance

Clough Global Equity Fund Section 19(a) Notice
HOOK

ACCESSWIRE

a year ago

Clough Global Equity Fund Section 19(a) Notice

Why You Might Be Interested In Parke Bancorp, Inc. (NASDAQ:PKBK) For Its Upcoming Dividend
HOOK

Simply Wall St.

2 years ago

Why You Might Be Interested In Parke Bancorp, Inc. (NASDAQ:PKBK) For Its Upcoming Dividend

MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads
HOOK

GlobeNewswire

2 years ago

MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads

HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
HOOK

GlobeNewswire

2 years ago

HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences

Emeren Group Sells a 53.6 MWp Solar Portfolio in Hungary
HOOK

PR Newswire

2 years ago

Emeren Group Sells a 53.6 MWp Solar Portfolio in Hungary

Share on Social Networks: